// App-Quantinova.ai

: Development of [18F]AldoView as the first highly selective aldosterone synthase PET tracer for imaging of patients with primary hyperaldosteronism

Researchers

Presenter

  • Kerstin Sander

Principal Investigators

  • Tom Kurzawinski

  • Thibault Gendron

  • Klaudia Cybulska

  • Fatih Sirindil

  • Junhua Zhou

  • Tammy Kalber

  • Mark Lythgoe

  • Morris Brown

  • Bryan Williams

  • Erik Arstad

Medical Centers

  • University College London, Centre for Radiopharmaceutical Chemistry, London, United Kingdom

  • University College Hospital, Endocrine Surgery, London, United Kingdom

  • University College London, Centre for Radiopharmaceutical Chemistry, London, United Kingdom

  • Barts and the London School of Medicine, London, United Kingdom

  • University College London, Centre for Advanced Biomedical Imaging, London, United Kingdom

  • NIHR University College London Hospitals Biomedical Research Centre, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Endocrine/metabolic Diseases (ME)

Disease

  • Primary aldosteronism

  • Pheochromocytoma

Biomarkers

  • 18F-fluorodeoxyglucose

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved